|
|
||||||||
B Elements1
Centre de Recherche en Infectiologie, Centre Hospitalier Universitaire de Québec, Pavillon du Centre Hospitalier de lUniversité Laval (CHUL), and Département de Biologie Médicale, Faculté de Médecine, Université Laval, Ste-Foy, Québec, Canada
We have recently demonstrated that the parasite Leishmania
donovani and its surface molecule, lipophosphoglycan (LPG), can
activate HIV-1 replication in monocytoid cells. Our present interest
was to determine whether LPG could also up-regulate HIV-1 transcription
in T cells. Using a CD4-positive human lymphoid T cell line (1G5)
containing a stably integrated HIV-1 long terminal repeat
(LTR)-luciferase construct, we found that LPG is a potent inducer of
HIV-1 LTR activity. Treatment of 1G5 cells with signaling antagonists
revealed that protein tyrosine kinase- and protein kinase A-dependent
pathways were actively participating in the LPG-induced enhancement of
HIV-1 LTR-driven activity. Transfection of Jurkat E6.1 cells with
plasmids containing wild-type and nuclear factor-
B (NF-
B)-mutated
HIV-1 LTR-luciferase constructs has suggested a role for NF-
B
binding sites in the LPG-mediated induction of HIV-1 LTR activity. An
LPG-induced binding factor specific to the NF-
B consensus sequences
could be observed using electrophoretic mobility shift assay. Finally,
transfection experiments performed with a vector containing HIV-1
B
binding sites only showed similar LPG-mediated induction, which was
abrogated by sodium salicylate, a known NF-
B inhibitor. We thus
demonstrate that the LPG-mediated induction of HIV-1 LTR activity in T
cells involves several second messengers culminating in activation of
HIV-1 LTR-driven transcription via NF-
B-binding consensus sequences.
In conclusion, these results reinforce the idea that L.
donovani is a putative cofactor in HIV-1 pathogenesis.
This article has been cited by other articles:
![]() |
J. Alvar, P. Aparicio, A. Aseffa, M. Den Boer, C. Canavate, J.-P. Dedet, L. Gradoni, R. Ter Horst, R. Lopez-Velez, and J. Moreno The Relationship between Leishmaniasis and AIDS: the Second 10 Years Clin. Microbiol. Rev., April 1, 2008; 21(2): 334 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zhao, S. Thibault, N. Messier, M. Ouellette, B. Papadopoulou, and M. J. Tremblay In primary human monocyte-derived macrophages exposed to Human immunodeficiency virus type 1, does the increased intracellular growth of Leishmania infantum rely on its enhanced uptake? J. Gen. Virol., May 1, 2006; 87(Pt 5): 1295 - 1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Guenthner, W. E. Secor, and C. S. Dezzutti Trichomonas vaginalis-Induced Epithelial Monolayer Disruption and Human Immunodeficiency Virus Type 1 (HIV-1) Replication: Implications for the Sexual Transmission of HIV-1 Infect. Immun., July 1, 2005; 73(7): 4155 - 4160. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zhao, B. Papadopoulou, and M. J. Tremblay Leishmania infantum Promotes Replication of HIV Type 1 in Human Lymphoid Tissue Cultured Ex Vivo by Inducing Secretion of the Proinflammatory Cytokines TNF-{alpha} and IL-1{alpha} J. Immunol., March 1, 2004; 172(5): 3086 - 3093. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. de la Rosa, J. A Pineda, J. Delgado, J. Macias, F. Morillas, J. A. Mira, A. Sanchez-Quijano, M. Leal, and E. Lissen Incidence of and Risk Factors for Symptomatic Visceral Leishmaniasis among Human Immunodeficiency Virus Type 1-Infected Patients from Spain in the Era of Highly Active Antiretroviral Therapy J. Clin. Microbiol., March 1, 2002; 40(3): 762 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wolday, H. Akuffo, A. Demissie, and S. Britton Role of Leishmania donovani and Its Lipophosphoglycan in CD4+ T-cell Activation-Induced Human Immunodeficiency Virus Replication Infect. Immun., October 1, 1999; 67(10): 5258 - 5264. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dumais, B. Barbeau, M. Olivier, and M. J. Tremblay Prostaglandin E2 Up-regulates HIV-1 Long Terminal Repeat-driven Gene Activity in T Cells via NF-kappa B-dependent and -Independent Signaling Pathways J. Biol. Chem., October 16, 1998; 273(42): 27306 - 27314. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |